Aytu Biopharma (AYTU) Retained Earnings (2011 - 2026)
Aytu Biopharma (AYTU) reported Retained Earnings of -$347.79 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$333.54 million a year earlier.
Powered by 
Analysis
Aytu Biopharma (AYTU) Retained Earnings (2011 - 2026) Analysis & Trends
Dating back to fiscal Q4 2011, Aytu Biopharma's Retained Earnings record includes 57 quarters.
- By fiscal year, Retained Earnings came in at -$333.54 million in FY2025, -$319.97 million in FY2024, -$304.13 million in FY2023 and -$287.1 million in FY2022.
- The fiscal Q4 2026 figure ranks as the lowest quarterly Retained Earnings in data going back to fiscal Q4 2011.
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at -$347.77 million (Q3 2026), -$342.15 million (Q2 2026) and -$331.57 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 37.97 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 168.36 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | -16.19 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 66.22 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 14.07 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | -19.81 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 3.11 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 115.33 Bn |
| 10 | Aytu Biopharma | 22.17 Mn | -93.50 Mn | 10.41 Mn | -347.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -347.79 Mn |
| Mar 31, 2026 | -347.77 Mn |
| Dec 31, 2025 | -342.15 Mn |
| Sep 30, 2025 | -331.57 Mn |
| Jun 30, 2025 | -333.54 Mn |
| Mar 31, 2025 | -313.72 Mn |
| Dec 31, 2024 | -317.71 Mn |
| Sep 30, 2024 | -318.50 Mn |
| Jun 30, 2024 | -319.97 Mn |
| Mar 31, 2024 | -315.40 Mn |
| Dec 31, 2023 | -312.50 Mn |
| Sep 30, 2023 | -312.25 Mn |
| Jun 30, 2023 | -304.13 Mn |
| Mar 31, 2023 | -301.70 Mn |
| Dec 31, 2022 | -294.50 Mn |
| Sep 30, 2022 | -287.80 Mn |
| Jun 30, 2022 | -287.10 Mn |
| Mar 31, 2022 | -270.80 Mn |
| Dec 31, 2021 | -217.70 Mn |
| Sep 30, 2021 | -206.20 Mn |
API Access
Aytu Biopharma Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();